1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy

Technology appraisal guidance [TA736] Published: 20 October 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 140 KB 20 October 2021  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 305 KB 15 September 2021  
  • Committee papers PDF 1.9 MB 15 September 2021  
  • Public committee slides PDF 776 KB 15 September 2021  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document (online commenting)  
  • Appraisal consultation document (PDF version) PDF 292 KB 07 January 2021  
  • Public committee slides PDF 274 KB 07 January 2021  
  • Committee papers PDF 3.58 MB 07 January 2021  

Invitation to participate

  • Final scope PDF 157 KB 30 January 2020  
  • Final stakeholder list PDF 187 KB 30 January 2020